Cargando…

Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging

BACKGROUND: Atropine sulfate is an anticholinergic agent for treatment of hypertrophic pyloric stenosis and is orally administrated as a triturate with lactose hydrate. Because of the low safety margin of atropine sulfate, triturate uniformity is a key safety factor. In this study, we assessed the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriyama, Kei, Takami, Yoichiro, Uozumi, Natsuki, Okuda, Akiko, Yamashita, Mayumi, Yokomizo, Rie, Shimada, Kenichi, Egawa, Takashi, Kamei, Takehito, Takayanagi, Kazunobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748566/
https://www.ncbi.nlm.nih.gov/pubmed/26865984
http://dx.doi.org/10.1186/s40780-016-0038-7
_version_ 1782415143133511680
author Moriyama, Kei
Takami, Yoichiro
Uozumi, Natsuki
Okuda, Akiko
Yamashita, Mayumi
Yokomizo, Rie
Shimada, Kenichi
Egawa, Takashi
Kamei, Takehito
Takayanagi, Kazunobu
author_facet Moriyama, Kei
Takami, Yoichiro
Uozumi, Natsuki
Okuda, Akiko
Yamashita, Mayumi
Yokomizo, Rie
Shimada, Kenichi
Egawa, Takashi
Kamei, Takehito
Takayanagi, Kazunobu
author_sort Moriyama, Kei
collection PubMed
description BACKGROUND: Atropine sulfate is an anticholinergic agent for treatment of hypertrophic pyloric stenosis and is orally administrated as a triturate with lactose hydrate. Because of the low safety margin of atropine sulfate, triturate uniformity is a key safety factor. In this study, we assessed the uniformity of atropine sulfate in 1000-fold triturates prepared by wet mixing and dry mixing methods and discussed the cause of the difference in uniformity between two preparation methods. METHODS: A 1000-fold triturate of atropine sulfate with lactose hydrate was prepared by two different methods: wet mixing and dry mixing. The wet mixing was performed according to Kurashiki Central Hospital protocol and the dry mixing was a simple physical mixing by a rocking mixer. The uniformity of atropine sulfate content in aliquots of a 1000-fold triturate with lactate hydrate was assessed by liquid chromatography–tandem mass spectrometry (LC–MS/MS) quantification. Solid-state analyses of the triturates by Raman chemical imaging and X-ray powder diffraction (XRPD) were performed to investigate the difference in uniformity. RESULTS: The LC–MS/MS quantification showed that the uniformity of atropine sulfate in the 1000-fold triturate was excellent for wet mixing but was significantly variable for dry mixing. On the basis of the Raman chemical imaging and XRPD analyses, it was indicated that an amorphous thin film of atropine sulfate coated the surfaces of the lactose hydrate particles during wet mixing and contributed to the uniformity of the triturate. In contrast, clusters of the crystalline atropine sulfate were found in the dry mixing samples. CONCLUSION: The results showed that better atropine sulfate triturate uniformity was achieved using the wet mixing method rather than the dry method and the cause of the uniformity difference between two mixing methods was indicated by the multilateral assessment.
format Online
Article
Text
id pubmed-4748566
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47485662016-02-11 Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging Moriyama, Kei Takami, Yoichiro Uozumi, Natsuki Okuda, Akiko Yamashita, Mayumi Yokomizo, Rie Shimada, Kenichi Egawa, Takashi Kamei, Takehito Takayanagi, Kazunobu J Pharm Health Care Sci Short Report BACKGROUND: Atropine sulfate is an anticholinergic agent for treatment of hypertrophic pyloric stenosis and is orally administrated as a triturate with lactose hydrate. Because of the low safety margin of atropine sulfate, triturate uniformity is a key safety factor. In this study, we assessed the uniformity of atropine sulfate in 1000-fold triturates prepared by wet mixing and dry mixing methods and discussed the cause of the difference in uniformity between two preparation methods. METHODS: A 1000-fold triturate of atropine sulfate with lactose hydrate was prepared by two different methods: wet mixing and dry mixing. The wet mixing was performed according to Kurashiki Central Hospital protocol and the dry mixing was a simple physical mixing by a rocking mixer. The uniformity of atropine sulfate content in aliquots of a 1000-fold triturate with lactate hydrate was assessed by liquid chromatography–tandem mass spectrometry (LC–MS/MS) quantification. Solid-state analyses of the triturates by Raman chemical imaging and X-ray powder diffraction (XRPD) were performed to investigate the difference in uniformity. RESULTS: The LC–MS/MS quantification showed that the uniformity of atropine sulfate in the 1000-fold triturate was excellent for wet mixing but was significantly variable for dry mixing. On the basis of the Raman chemical imaging and XRPD analyses, it was indicated that an amorphous thin film of atropine sulfate coated the surfaces of the lactose hydrate particles during wet mixing and contributed to the uniformity of the triturate. In contrast, clusters of the crystalline atropine sulfate were found in the dry mixing samples. CONCLUSION: The results showed that better atropine sulfate triturate uniformity was achieved using the wet mixing method rather than the dry method and the cause of the uniformity difference between two mixing methods was indicated by the multilateral assessment. BioMed Central 2016-02-10 /pmc/articles/PMC4748566/ /pubmed/26865984 http://dx.doi.org/10.1186/s40780-016-0038-7 Text en © Moriyama et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Moriyama, Kei
Takami, Yoichiro
Uozumi, Natsuki
Okuda, Akiko
Yamashita, Mayumi
Yokomizo, Rie
Shimada, Kenichi
Egawa, Takashi
Kamei, Takehito
Takayanagi, Kazunobu
Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging
title Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging
title_full Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging
title_fullStr Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging
title_full_unstemmed Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging
title_short Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging
title_sort assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, x-ray powder diffraction, and raman chemical imaging
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748566/
https://www.ncbi.nlm.nih.gov/pubmed/26865984
http://dx.doi.org/10.1186/s40780-016-0038-7
work_keys_str_mv AT moriyamakei assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT takamiyoichiro assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT uozuminatsuki assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT okudaakiko assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT yamashitamayumi assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT yokomizorie assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT shimadakenichi assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT egawatakashi assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT kameitakehito assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging
AT takayanagikazunobu assessmentofdrugcontentuniformityofatropinesulfatetrituratebyliquidchromatographytandemmassspectrometryxraypowderdiffractionandramanchemicalimaging